In renal cancer, AIM2 can induce the transformation of anti-inflammatory M2 to pro-inflammatory M1 by enhancing the inflammasome pathway, thus inhibiting tumor progression (Chai et al., 2021). This evidence concerns the gene AIM2 and neoplasm.